Ajjan RA - Search Results

1

Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics.

Pechlivani N, Kearney KJ, Ajjan RA. Pechlivani N, et al. Among authors: ajjan ra. Int J Mol Sci. 2021 Nov 21;22(22):12537. doi: 10.3390/ijms222212537. Int J Mol Sci. 2021. PMID: 34830419 Free PMC article. Review.

2

Complement C3 is a novel plasma clot component with anti-fibrinolytic properties.

Howes JM, Richardson VR, Smith KA, Schroeder V, Somani R, Shore A, Hess K, Ajjan R, Pease RJ, Keen JN, Standeven KF, Carter AM. Howes JM, et al. Diab Vasc Dis Res. 2012 Jul;9(3):216-25. doi: 10.1177/1479164111432788. Epub 2012 Jan 17. Diab Vasc Dis Res. 2012. PMID: 22253322 Free article.

3

Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.

Kearney K, Tomlinson D, Smith K, Ajjan R. Kearney K, et al. Cardiovasc Diabetol. 2017 Mar 9;16(1):34. doi: 10.1186/s12933-017-0515-9. Cardiovasc Diabetol. 2017. PMID: 28279217 Free PMC article. Review.

4

Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets.

Pechlivani N, Ajjan RA. Pechlivani N, et al. Among authors: ajjan ra. Front Cardiovasc Med. 2018 Jan 19;5:1. doi: 10.3389/fcvm.2018.00001. eCollection 2018. Front Cardiovasc Med. 2018. PMID: 29404341 Free PMC article. Review.

5

Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications.

Kearney KJ, Pechlivani N, King R, Tiede C, Phoenix F, Cheah R, Macrae FL, Simmons KJ, Manfield IW, Smith KA, Spurgeon BEJ, Naseem KM, Ariens RAS, McPherson MJ, Tomlinson DC, Ajjan RA. Kearney KJ, et al. Among authors: ajjan ra. Blood. 2019 Mar 14;133(11):1233-1244. doi: 10.1182/blood-2018-06-856195. Epub 2018 Dec 13. Blood. 2019. PMID: 30545831 Free PMC article.

6

Reduced Plasma Magnesium Levels in Type-1 Diabetes Associate with Prothrombotic Changes in Fibrin Clotting and Fibrinolysis.

Sobczak AIS, Phoenix FA, Pitt SJ, Ajjan RA, Stewart AJ. Sobczak AIS, et al. Among authors: ajjan ra. Thromb Haemost. 2020 Feb;120(2):243-252. doi: 10.1055/s-0039-3402808. Epub 2020 Jan 3. Thromb Haemost. 2020. PMID: 31942750 Free PMC article.

7

Prothrombotic fibrin network characteristics in patients with acromegaly: a novel mechanism for vascular complications.

Kyriakakis N, Pechlivani N, Lynch J, Oxley N, Phoenix F, Seejore K, Orme SM, Ajjan R, Murray RD. Kyriakakis N, et al. Eur J Endocrinol. 2020 May;182(5):511-521. doi: 10.1530/EJE-19-0817. Eur J Endocrinol. 2020. PMID: 32197236 Free article.

8

Circulating MicroRNA Levels Indicate Platelet and Leukocyte Activation in Endotoxemia Despite Platelet P2Y₁₂ Inhibition.

Braza-Boïls A, Barwari T, Gutmann C, Thomas MR, Judge HM, Joshi A, Pechlaner R, Shankar-Hari M, Ajjan RA, Sabroe I, Storey RF, Mayr M. Braza-Boïls A, et al. Among authors: ajjan ra. Int J Mol Sci. 2020 Apr 21;21(8):2897. doi: 10.3390/ijms21082897. Int J Mol Sci. 2020. PMID: 32326325 Free PMC article.

9

Fibrinogen interaction with complement C3: a potential therapeutic target to reduce thrombosis risk.

King RJ, Schuett K, Tiede C, Jankowski V, John V, Trehan A, Simmons K, Ponnambalam S, Storey RF, Fishwick CWG, McPherson MJ, Tomlinson DC, Ajjan RA. King RJ, et al. Among authors: ajjan ra. Haematologica. 2021 Jun 1;106(6):1616-1623. doi: 10.3324/haematol.2019.239558. Haematologica. 2021. PMID: 32354869 Free PMC article.

10

Maturity onset diabetes of the young and fibrin-related thrombosis risk.

Sagar RC, Phoenix F, Thanabalasingham G, Naseem K, Ajjan RA, Owen KR. Sagar RC, et al. Among authors: ajjan ra. Diab Vasc Dis Res. 2020 Nov-Dec;17(6):1479164120963048. doi: 10.1177/1479164120963048. Diab Vasc Dis Res. 2020. PMID: 33334146 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page